Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Cash Flows (Unaudited)

v3.23.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
 3 Months Ended 12 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Dec. 31, 2022
CASH FLOWS FROM OPERATING ACTIVITIES      
Net Loss $ (7,236,000) $ (7,916,000)  
Adjustments to reconcile net loss to net cash used in operating activities:      
Depreciation and amortization 1,337,000 1,348,000  
Stock-based compensation 783,000 1,099,000  
Amortization of convertible notes discount 40,000 0  
Changes in assets and liabilities:      
Accounts receivable 2,671,000 543,000  
Prepaid expense and other current assets 140,000 215,000  
Accounts payable and accrued expense (919,000) (1,527,000)  
Accrued contingent consideration (Note 4) 468,000 0  
Deferred revenue (82,000) (3,000)  
Deferred taxes 0 (46,000)  
Accrued interest on note payable (180,000) 0  
Net cash used in operating activities (2,978,000) (6,287,000)  
CASH FLOWS FROM INVESTING ACTIVITIES      
Purchase of property and equipment (6,000) (118,000)  
Capitalization of software development costs (281,000) (297,000)  
Acquisition of other intangible assets (7,000) (47,000)  
Net cash used in investing activities (294,000) (462,000)  
CASH FLOWS FROM FINANCING ACTIVITIES      
Proceeds from issuance of preferred stock, net of issuance costs (Note 6) 1,919,000 0 $ 8,926,000
Payments on convertible notes (Note 5) (539,000) 0  
Net cash provided by financing activities 1,380,000 0  
DECREASE IN CASH (1,892,000) (6,749,000)  
Cash and Cash Equivalents - beginning of period 2,482,000 14,533,000 14,533,000
Cash and Cash Equivalents - end of period $ 590,000 $ 7,784,000 $ 2,482,000